Cornerstone Investment Partners, LLC Innoviva, Inc. Transaction History

Cornerstone Investment Partners, LLC

  • $1.91 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$14.4 - $16.4 $10,065 - $11,463
-699 Reduced 6.34%
10,334 $169,000
Q4 2023

Jan 31, 2024
BUY
$12.32 - $16.27 $135,926 - $179,506
11,033 New
11,033 $176,000
Q2 2020

Jul 30, 2020
SELL
$11.49 - $15.26 $126,240 - $167,661
-10,987 Closed
0 $0
Q1 2020

Apr 27, 2020
SELL
$8.11 - $15.23 $527 - $989
-65 Reduced 0.59%
10,987 $129,000
Q4 2019

Jan 29, 2020
BUY
$10.28 - $14.38 $113,614 - $158,927
11,052 New
11,052 $156,000

Others Institutions Holding INVA

# of Institutions
228
Shares Held
79.1M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email